Zhongke Xinyun Biotechnology

Zhongke Xinyun Biotechnology is a high-tech enterprise focused on the early detection and precision monitoring of tumors through advanced molecular diagnostics. Leveraging technologies such as high-throughput sequencing and DNA methylation analysis, the company has developed a suite of non-invasive liquid biopsy products for various gastrointestinal and abdominal cancers. Their core business revolves around providing early screening solutions that are highly sensitive and specific, aiming to improve patient outcomes through early intervention. The company integrates R&D, clinical transformation, and medical testing services to support the full lifecycle of cancer management.